By Ben Adams
Humanigen is prepping its COVID-19 drug lenzilumab for an emergency use authorization with the FDA before the month’s end.
read more
By Beth Snyder Bulik
What was going through the minds of the FDA officials during the earliest days of the COVID-19 pandemic? Thanks to hundreds of emails released by the FDA on Thursday—forced through the Freedom of Information Act—enquiring minds can find out. It's still just a glimpse, however, as quite a bit of the text copy, subject lines and emails are blacked out for confidentially reasons.
read more
By Paige Minemyer
The pandemic has accelerated employers' interest in offering voluntary benefits such as hospital indemnity coverage to workers, a new survey shows.
read more
By Noah Higgins-Dunn,Kevin Dunleavy,Fraiser Kansteiner
The U.K. plans to accelerate its vaccine rollout as a coronavirus variant first identified in India, and likely more transmissible than previous strains, begins to spread across the nation. The World Health Organization is asking rich countries to donate vaccines before using them in children. And more headlines.
read more